Thank you for your interest in the Cogent Biosciences sponsored Industry Session titled Innovation in Targeting the Underlying Mechanism of Disease in Nonadvanced Systemic Mastocytosis: Emerging Clinical Insights and Patient Case Perspectives With Bezuclastinib on Friday, May 15, 2026, from 3:00-4:30pm ET in the Michigan Union, Room 2210 (2nd Floor). Please complete the official registration form below. Once your registration is complete, you will receive a calendar invitation.
